Welcome to Your Portfolia Member Hub
MERCY BIO SPV OPPORTUNITY
Portfolia is offering members an exclusive opportunity to invest directly in Mercy BioAnalytics, one of the most promising companies in early cancer detection.
As a Portfolia Investing Member, you’re receiving confidential access to a $1M–$1.5M allocation in Mercy’s Series B. This follows a $68M raise to date, including significant institutional backing, and comes as the company enters a major growth phase with breakthrough regulatory momentum and platform readiness.
The Portfolia team is hosting a live investor overview session on May 21 at 1:00 PM PST, led by Trish Costello, CEO & Founder of Portfolia, and Dawn Mattoon, PhD, CEO of Mercy Bio
Monthly Newsletter Highlights
WE’RE FEATURED IN BUSINESS INSIDER!
Portfolia Founder & CEO Trish Costello was recognized by Business Insider as one of 2025’s top women early-stage investors for her consistent leadership and bold investments across women’s health, sustainability, and diverse founders — even as others pulled back. "The smartest trend was to stay consistent and disciplined and keep putting our money to work,” Trish told BI.
LATEST INVESTMENTS
FemTech III Fund: Lōvu
Lōvu is redefining maternal health with a comprehensive digital platform that supports both parent and baby from conception through postpartum. In a market long underserved by traditional healthcare, Lōvu is closing critical gaps with culturally competent, continuous care—delivering better outcomes for families and reducing costs for providers and payers. Lōvu is scaling to meet surging demand in the $160B+ global maternal and infant health market.
Green & Sustainability Fund: Dorothy
Dorothy is transforming how property owners recover from natural disasters — making the process faster, smarter, and more equitable through advanced AI and climate data. As climate change accelerates the frequency and severity of extreme weather events, the need for scalable disaster recovery solutions is more urgent than ever.
2025 PORTFOLIA ANNUAL INVESTOR SUMMIT RECAP
The 2025 Portfolia Annual Investor Summit was a celebration of what happens when visionary investors, trailblazing founders, and values-driven fund partners come together to shape the future of investing.
RISING AMERICA III FUND - INTRO TO NEW PARTNER
We're excited to welcome Sheila D. Collins as the newest Fund Partner for Rising America III. View the recording to hear about Sheila’s expertise and fund landscape overview. The Rising America Fund’s 31% net IRR puts it in the top 5%—proof that investing in diverse founders is a winning strategy.
WOMEN’S IV FUND NOW TAKING RESERVATIONS
Portfolia is the most active investor in women’s health with the US, with 60+ investments in fast-growth women’s health companies. We are launching our Women’s IV Fund soon to build off of our successful models from our FemTech funds. Join the waitlist today for priority access.
